Abstract:Ethnopharmacological relevance: YiXinShu capsule (YXSC), originally from the classical TCM formula named "Sheng-Mai-San", has been extensively utilized in clinic for the treatment of cardiovascular diseases. However, there were few reports about the quality assessment of YXSCs both internationally and domestically. Aim of the study: The objective was to develop a multi-strategy platform incorporating systematic quantitative fingerprint analysis and antioxidant activity determination, with chemometric analysis and bivariate correlation analysis as the auxiliary approaches, to assess and monitor the quality of YXSCs. Materials and methods: Firstly, according to the Chinese Pharmacopoeia (2020 edition), 12 key indicator components from seven herb medicines were quantified by HPLC method. Then, three-dimensional fingerprints comprising five-wavelength fusion fingerprint (FWF-FP), electrochemical fingerprint (EC-FP) and Differential Scanning Calorimetry fingerprint (DSC-FP) were established to assess and monitor YXSCs using systematically quantified fingerprint method (SQFM) and principal component analysis (PCA). Moreover, by integrating the analysis of the three-dimensional fingerprints, the quality of YXSCs from different batches was effectively screened. Finally, the antioxidant activity of this TCM was assessed through DPPH and ABTS methods, and the L-ascorbic acid equivalent antioxidant capacity (AEAC) values were compared to evaluate the antioxidant activities of the two methods. A Partial Least Squares (PLS) model was used to develop the spectrum-activity relationship between FWF-FP and AEAC, and a bivariate correlation analysis (BCA) was used to assess the correlation between FWF-FP and EC-FP. Results: The key indexes including tanshinone I, tol, toe, Atp, first exothermic peak, and second exothermic peak can differentiate between various batches of YXSCs based on their three-dimensional fingerprint profiles. The integration evaluation results from 42 batches of YXSCs were categorized into 2-5 grades, indicating good quality consistency across different batches. In vitro studies have indicated a significant antioxidant activity capacity of YXSCs. The PLS model revealed that 37 out of the 41 fingerprint peaks exhibited antioxidant activity. The overall trend of BCA was consistent with PLS model results. Conclusion: This research presents a scientific and holistic strategy for the quality consistency evaluation of YXSCs, thereby offering an effective approach for the thorough evaluation of TCMs.

An Image-Based Fingerprint-Efficacy Screening Strategy for Uncovering Active Compounds with Interactive Effects in Yindan Xinnaotong Soft Capsule.

Rapid Identification of Anti-Inflammatory Compounds from Tongmai Yangxin Pills by Liquid Chromatography with High-Resolution Mass Spectrometry and Chemometric Analysis

Comprehensive Chemical Profiling of Yindan Xinnaotong Soft Capsule and Its Neuroprotective Activity Evaluation in Vitro.

A Sensitive LC-MS/MS Method-Based Pharmacokinetic Study of Fifteen Active Ingredients of Yindan Xinnaotong Soft Capsule in Rats and Its Potential Mechanism in the Treatment of Cardiovascular Diseases.

Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses

Uncovering Potential Anti-Neuroinflammatory Components of Modified Wuziyanzong Prescription Through a Target-Directed Molecular Docking Fingerprint Strategy.

Identification of nuclear factor-κB inhibitors and β2 adrenergic receptor agonists in Chinese medicinal preparation Fuzilizhong pills using UPLC with quadrupole time-of-flight MS

Pharmacokinetic study of Yindan Xinnaotong soft capsule after oral administration in rats and its network pharmacology-based analysis on cardiovascular diseases

Identification Of Nuclear Factor-Kappa B Inhibitors And Beta(2) Adrenergic Receptor Agonists In Chinese Medicinal Preparation Fuzilizhong Pills Using Uplc With Quadrupole Time-Of-Flight Ms

Bioactivity-integrated Ultra-Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry for the Identification of Nuclear Factor-Κb Inhibitors and Β2 Adrenergic Receptor Agonists in Chinese Medicinal Preparation Chuanbeipipa Dropping Pills.

Screening and Analysis of Key Active Constituents in Guanxinshutong Capsule Using Mass Spectrum and Integrative Network Pharmacology.

TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome

Identification of absorbed constituents and evaluation of the pharmacokinetics of main compounds after oral administration of yindanxinnaotong by UPLC-Q-TOF-MS and UPLC-QqQ-MS

Holistic quality assessment and monitoring of YiXinShu capsule based on three-dimensional fingerprints combined with quantitative analysis, antioxidant activity and chemometrics

A novel strategy for the multi-components division and discovering pharmacodynamic material basis of Chinese herbal compounds: A case study of Xian-Ling-Gu-Bao capsule

Integrated Network Pharmacology and UPLC/Q-TOF-MS Screen System to Exploring Anti-Inflammatory Active Components and Mechanism of Shunaoxin Pills

Mechanism of baixiangdan capsules on anti-neuroinflammation: combining dry and wet experiments

Dual-bioactivity-based liquid chromatography-coupled quadrupole time-of-flight mass spectrometry for NF-κB inhibitors and β 2 AR agonists identification in Chinese Medicinal Preparation Qingfei Xiaoyan Wan

Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response

A Strategy for the Identification of Combinatorial Bioactive Compounds Contributing to the Holistic Effect of Herbal Medicines

Rapid discovery and identification of anti-inflammatory constituents from traditional Chinese medicine formula by activity index, LC-MS, and NMR